ArticleOncotarget2016

Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.

Nina Lapke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.